151 related articles for article (PubMed ID: 12708957)
1. Iontophoretic administration of prostaglandin E1 in peripheral arterial occlusive disease.
Sakurai T; Yamamura K
Ann Pharmacother; 2003 May; 37(5):747. PubMed ID: 12708957
[No Abstract] [Full Text] [Related]
2. A new surgical approach to vasodilating therapy in peripheral occlusive vascular disease.
Horch R; Krönung G
Nihon Geka Hokan; 1988 Nov; 57(6):487-92. PubMed ID: 3268061
[No Abstract] [Full Text] [Related]
3. [Mechanisms of action of prostaglandin E1 in therapy of peripheral arterial occlusive diseases].
Weiss T
Vasa; 2003 Nov; 32(4):187-92. PubMed ID: 14694766
[TBL] [Abstract][Full Text] [Related]
4. Intra-arterial and intravenous administration of prostaglandin E1 cause different changes to skin microcirculation in patients with peripheral arterial occlusive disease.
Thum J; Caspary L; Creutzig A; Alexander K
Vasa; 1998 May; 27(2):100-5. PubMed ID: 9612114
[TBL] [Abstract][Full Text] [Related]
5. Effect of prostaglandin E1 upon collateral vessels in peripheral occlusive arterial disease.
Rudofsky G; Gerngross U
Prog Clin Biol Res; 1989; 301():407-9. PubMed ID: 2798455
[No Abstract] [Full Text] [Related]
6. Intravenous prostaglandin E1 reduces monocyte chemoattractant protein-1 levels in peripheral arterial obstructive disease.
Matsui K; Ikeda U; Murakami Y; Yoshioka T; Shimada K
Am Heart J; 2003 Feb; 145(2):330-3. PubMed ID: 12595852
[TBL] [Abstract][Full Text] [Related]
7. [Prostaglandins including prostacyclin in the treatment of peripheral arterial occlusive disorders].
Alexander K
Internist (Berl); 1989 Jul; 30(7):429-39. PubMed ID: 2670810
[No Abstract] [Full Text] [Related]
8. Neutrophil function in peripheral arterial occlusive disease: the effects of prostaglandin E1.
Weiss T; Eckstein H; Weiss C; Diehm C
Vasc Med; 1998; 3(3):171-5. PubMed ID: 9892509
[TBL] [Abstract][Full Text] [Related]
9. Effects of intravenous prostaglandin E1 on arterial compliance: a randomized controlled trial.
Mlekusch W; Schillinger M; Sabeti S; Al-Awami M; Gschwandtner M; Minar E
Vasa; 2004 Aug; 33(3):131-6. PubMed ID: 15461064
[TBL] [Abstract][Full Text] [Related]
10. [Microcirculation in peripheral arterial occlusive diseases will improve. Prostaglandin can prevent surgery].
MMW Fortschr Med; 2003 Dec; 145(51-52):41. PubMed ID: 14974333
[No Abstract] [Full Text] [Related]
11. Chronic arterial occlusion with PGE1-resistant skin lesions treated by glycosaminoglycan compound--case reports.
Nakashima Y; Segawa J; Kawashima T; Fukuchi Y; Kuroiwa A
Angiology; 1990 Sep; 41(9 Pt 1):731-6. PubMed ID: 1977336
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin Injection After Arterial Compromise Related to Hyaluronic Acid Filler.
Megías-Vericat JE; Ricart JM; Ribes-Artero H; Poveda JL
Dermatol Surg; 2017 Jul; 43(7):975-977. PubMed ID: 28178006
[No Abstract] [Full Text] [Related]
13. Case of inhaled prostaglandin E1 used to improve hypoxia in ARDS.
Siddiqui S; Zubair S; Khan FH
J Pak Med Assoc; 2004 Dec; 54(12):635-6. PubMed ID: 16104494
[No Abstract] [Full Text] [Related]
14. Prostaglandin E1 in the therapy of erectile deficiency.
Beretta G; Zanollo A; Ascani L; Re B
Acta Eur Fertil; 1989; 20(5):305-8. PubMed ID: 2636808
[TBL] [Abstract][Full Text] [Related]
15. Recount of prostaglandin E1 therapy in a patient with Raynaud's phenomenon.
DiGiovanni RL; Littlefield JM; Good RG
J Am Osteopath Assoc; 1995 Oct; 95(10):572. PubMed ID: 8557544
[No Abstract] [Full Text] [Related]
16. Effects of intra-arterial prostaglandin E1 in patients with peripheral arterial occlusive disease.
Creutzig A; Creutzig H; Alexander K
Eur J Clin Invest; 1986 Dec; 16(6):480-5. PubMed ID: 3104047
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of continuous intra-arterial administration of prostaglandin E1, urokinase and heparin for intractable digital ulcers by upper extremity arterial occlusion in diffuse cutaneous systemic sclerosis patient.
Numata S; Iwata Y; Kobayashi M; Sato T; Sugiura K
J Dermatol; 2017 Oct; 44(10):e254-e255. PubMed ID: 28691232
[No Abstract] [Full Text] [Related]
18. Haemodynamic effects of intra-arterial and intravenous administration of prostaglandin E1 in patients with peripheral arterial disease.
Hirai M; Nakayama R
Br J Surg; 1986 Jan; 73(1):20-3. PubMed ID: 3947867
[TBL] [Abstract][Full Text] [Related]
19. Does alprostadil cream hit the spot?
Drug Ther Bull; 2015 Feb; 53(2):21-4. PubMed ID: 25678352
[TBL] [Abstract][Full Text] [Related]
20. Application of lipid microspheres containing prostaglandin E1 ointment to peripheral ischemic ulcers.
Sakakibara Y; Jikuya T; Mitsui T
Dermatology; 1997; 195(3):253-7. PubMed ID: 9407173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
